Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study

Molecular Psychiatry

Volumn 16, Issue 1, 2011, Pages 108-120

  Voyiaziakis, E ^a   Evgrafov, O ^a   Li, D ^a   Yoon, H J ^a   Tabares, P ^b   Samuels, J ^c   Wang, Y ^c   Riddle, M A ^c   Grados, M A ^c   Bienvenu, O J ^c   Shugart, Y Y ^d   Liang, K Y ^d   Greenberg, B D ^e   Rasmussen, S A ^e   Murphy, D L ^f   Wendland, J R ^f   McCracken, J T ^g   Piacentini, J ^g   Rauch, S L ^h   Pauls, D L ^h   Nestadt, G ^c   Fyer, A J ^b   Knowles, J A ^a   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Columbia University ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e BUTLER HOSPITAL   (United States)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

affected sib pair study; family study; heterogeneity analysis; molecular haplotype analysis; OCD genetics; serotonin transporter

Indexed keywords

SEROTONIN TRANSPORTER;

ARTICLE; DOMINANT INHERITANCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; INDEL MUTATION; INTRON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR FAMILY; OBSESSIVE COMPULSIVE DISORDER; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 78650510114     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2009.100     Document Type: Article

References (72)

1. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD et al. Serotonin transporter promoter gain-of-function genotypes are linked to OCD. Am J Hum Genet 2006; 78: 815-826.
2. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 2003; 8: 933-936. (Pubitemid 37421700)
3. Nestadt G, Lan T, Samuels J, Riddle M, Bienvenu III OJ, Liang KY et al. Complex segregation analysis provides compelling evidence for a major gene underlying OCD for heterogeneity by sex. Am J Hum Genet 2000; 67: 1611-1616.
4. Nestadt G, Samuels J, Riddle M, Bienvenu III OJ, Liang KY, Labuda M et al. A family study of OCD. Arch Gen Psychiatry 2000; 57: 358-363.
5. Hanna GL, Fingerlin TE, Himle JA, Boehnke M. Complex segregation analysis of OCD in families with pediatric probands. Hum Hered 2005; 60: 1-9.
6. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC et al. Genome-wide linkage analysis of families with OCD ascertained through pediatric probands. Am J Med Genet 2002; 114: 541-552.
7. Willour VL, Yao SY, Samuels J, Grados M, Cullen B, Bienvenu III OJ et al. Replication study supports evidence for linkage to 9p24 in OCD. Am J Hum Genet 2004; 75: 508-513.
8. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with OCD. Arch Gen Psychiatry 2006; 63: 769-776.
9. Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C et al. Association of the SLC1A1 glutamate transporter gene OCD. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 1027-1033.
10. Dickel DE, Veenstra-VanderWeele J, Bivens NC, Wu X, Fischer DJ, Van Etten-Lee M et al. Association studies of serotonin system candidate genes in early-onset OCD. Biol Psychiatry 2007; 61: 322-329.
11. Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG et al. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with OC. Arch Gen Psychiatry 2009; 66: 408-416.
12. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA et al. Genome-wide linkage scan for OCD: evidence for susceptibility loci on chromosomes 3q 7p 1q 15q 6q. Mol Psychiatry 2006; 11: 763-770.
13. Goddard AW, Shekhar A, Whiteman AF, McDougle CJ. Serotoni-nergic mechanisms in the treatment of OCD. Drug Discov Today 2008; 13: 325-332.
14. Stengler-Wenzke K, Muller U, Angermeyer MC, Sabri O, Hesse S. Reduced serotonin transporter-availability in OCD. Eur Arch Psychiatry Clin Neurosci 2004; 254: 252-255.
15. Hesse S, Müller U, Lincke T, Barthel H, Villmann T, Angermeyer MC et al. Serotonin dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res 2005; 140: 63-72.
16. Hasselbalch SG, Hansen ES, Jakobsen TB, Pinborg LH, Lønborg JH, Bolwig TG. Reduced midbrain-pons serotonin transporter binding in patients with OCD. Acta Psychiatr Scand 2007; 115: 388-394.
17. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC et al. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci USA 2005; 102: 11545-11550.
18. Roberts J, Scott AC, Howard MR, Breen G, Bubb VJ, Klenova E et al. Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat. J Neurosci 2007; 27: 2793-2801.
19. Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V et al. Association of the SERT polymorphism and OCD: Systematic review. Am J Med Genet B Neuropsych Genet 2008; 147B: 850-858.
20. McDougle CJ, Epperson CN, Price LH, Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and OCD. Mol Psychiatry 1998; 3: 270-273.
21. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q et al. Association of the serotonin transporter promoter regulatory region polymorphism and OCD. Mol Psychiatry 1999; 4: 463-466.
22. Camarena B, Rinetti G, Cruz C, Hernandez S, de la Fuente JR, Nicolini H. Association study of the serotonin transporter gene polymorphism in OCD. Int J Neuropsychopharmacol 2001; 4: 269-272.
23. Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 2002; 114: 347-353.
24. Di Bella D, Erzegovesi S, Cavallini MC, Bellodi L. OCD, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J 2002; 2: 176-181.
25. Kim SJ, Lee HS, Kim CH. OCD, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology 2005; 52: 176-182.
26. Kinnear CJ, Niehaus DJ, Moolman-Smook JC, du Toit PL, van Kradenberg J, Weyers JB et al. OCD and the promoter region polymorphism (5- HTTLPR) in the serotonin transporter gene (SLC6A4): a negative association study in the Afrikaner population. Int J Neuropsychopharmacol 2000; 3: 327-331.
27. Frisch A, Finkel B, Michaelovsky E, Sigal M, Laor N, Weizman R. A rare short allele of the serotonin transporter promoter region (5- HTTLPR) found in an aggressive schizophrenic patient of Jewish Libyan origin. Psychiatr Genet 2000; 10: 179-183.
28. Walitza S, Wewetzer C, Gerlach M, Klampfl K, Geller F, Barth N et al. Transmission disequilibrium studies in children and adolescents with OCD pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm 2004; 111: 817-825.
29. Chabane N, Millet B, Delorme R, Lichtermann D, Mathieu F, Laplanche JL et al. Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and OCD by case control and family association study in humans. Neurosci Lett 2004; 363: 154-156.
30. Lin PY. Meta-analysis of the association of serotonin transporter gene polymorphism with OCD. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 683-689.
31. Kilic F, Murphy DL, Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 2003; 64: 440-446.
32. Wendland JR, DeGuzman TB, McMahon F, Rudnick G, Tera-Wadleigh SD, Murphy DL. SERT Ileu425Val in autism, Asperger syndrome and OCD. Psychiatr Genet 2008; 18: 31-39.
33. Samuels JF, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL et al. The OCD collaborative genetics study: methods and sample description. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 201-207.
34. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000; 50: 211-223.
35. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-306.
36. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2001; 68: 1065-1067.
37. Conneely KN, Boehnke M. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 2007; 81; (e-pub ahead of print).
38. Kraft P, Stram DO. Re: the use of inferred haplotypes in downstream analysis. Am J Hum Genet 2007; 81: 863-865.
39. Sinnwell JP, Schaid DJ, Yu Z. R Development Core Team. R: a language and environment for statistical computing. 2008. ISBN 3-900051-07-0, URL http://www.R-project.org.
40. Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous. R package version 1.3.8.
41. URL http://mayoresearch.mayo.edu/mayo/research/schaid/software.cfm.
42. Flattem NL, Blakely RD. Modified structure of the human serotonin transporter promoter. Mol Psychiatry 2000; 5: 110-115.
43. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000; 5: 32-38.
44. Enoch MA, Greenberg BD, Murphy DL, Goldman D. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with OCD. Biol Psychiatry 2001; 49: 385-388.
45. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to OCD. Biol Psychiatry 1999; 45: 1178-1189.
46. Alsobrook JP, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. Association between the COMT locus and OCD in females but not males. Am J Med Genet 2002; 114: 116-120.
47. Denys D, Van NF, Deforce D, Westenberg HG. Association between serotonergic candidate genes and specific phenotypes of OCD. J Affect Disord 2006; 91: 39-44.
48. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996; 347: 731-733.
49. Battersby S, Ogilvie AD, Smith CA, Blackwood DH, Muir WJ, Quinn JP et al. Structure of a variable number tandem repeat of the SERT gene and association with affective disorder. Psychiatr Genet 1996; 6: 177-181.
50. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 1996; 7: 1675-1679.
51. Fan JB, Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 2005; 10: 928-938, 891. (Pubitemid 41486485)
52. Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L. Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 2004; 9: 587-593.
53. Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K, Ohara K. A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharm Biol Psychiatry 1999; 23: 55-65.
54. Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH et al. Influence of SERTPR and STin2 on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry 2004; 9: 433-441.
55. Baca-Garcia E, Vaquero-Lorenzo C, Diaz-Hernandez M, Rodriguez-Salgado B, Dolengevich-Segal H, Arrojo-Romero M et al. Association between OCD and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 416-420.
56. Hranilovic D, Stefulj J, Schwab S, Borrmann-Hassenbach M, Albus M, Jernej B et al. SERT promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 2004; 55: 1090-1094.
57. MacKenzie A, Quinn J. A SERT gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 1999; 96: 15251-15255.
58. Lovejoy EA, Scott AC, Fiskerstrand CE, Bubb VJ, Quinn JP. The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit. Eur J Neurosci 2003; 17: 417-420.
59. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
60. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the SERT promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83-87.
61. Altemus M, Murphy DL, Greenberg B, Lesch KP. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. Am J Med Genet 1996; 67: 409-411.
62. Wendland JR, Moya PR, Kruse MR, Ren-Patterson RF, Jensen CL, Timpano KR et al. A novel, putative gain-of-function haplotype at SLC6A4 associates with OCD. Hum Mol Genet 2008; 17: 717-723.
63. Martin J, Cleak J, Willis-Owen SA, Flint J, Shifman S. Mapping regulatory variants for the serotonin transporter gene based on allelic expression imbalance. Mol Psychiatry 2007; 12: 421-422.
64. Kim SJ, Herzing LB, Veenstra-Vanderweele J, Lord C, Courchesne R, Leventhal BL et al. Mutation screening and transmission disequilibrium study of ATP10C in autism. Am J Med Genet 2002; 114: 137-143.
65. Kraft JB, Slager SL, McGrath PJ, Hamilton SP. Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 2005; 58: 374-381.
66. Delorme R, Betancur C, Wagner M, Krebs MO, Gorwood P, Pearl P et al. Support for association between the rare functional variant I425V of the serotonin transporter gene and susceptibility to OCD. Mol Psychiatry 2005; 10: 1059-1061.
67. Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH et al. Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet 2001; 27: 435-438.
68. Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL et al. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharm 2008; 33: 353-360.
69. Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y et al. No association of serotonin transporter gene (SLC6A4) with schizophrenia and bipolar disorder in Japanese patients: association analysis based on linkage disequilibrium. J Neural Transm 2006; 113: 899-905.
70. Levenstien MA, Ott J, Gordon D. 2006 Are molecular haplotypes worth the time and expense? A cost-effective method for applying molecular haplotypes. PLoS Genet 2006; 2: e127.
71. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korch-ynskyi O, Makarov SS et al. Human COMT haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006; 314: 1930-1933.
72. Nicodemus KK, Liu W, Chase GA, Tsai Y-Y, Fallin MD. Comparison of type I error for multiple test corrections in large single-nucleotide polymorphism studies using principal components versus haplotype blocking algorithms. BMC Genetics 2005; 6(Suppl 1): S78.